Ro 48-8071
CAS No. 161582-11-2
Ro 48-8071 ( Ro-488071 )
产品货号. M12352 CAS No. 161582-11-2
A potent 2,3-oxidosqualene cyclase (OSC) inhibitor with IC50 of 6.5 nM.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥7857 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ro 48-8071
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述A potent 2,3-oxidosqualene cyclase (OSC) inhibitor with IC50 of 6.5 nM.
-
产品描述A potent 2,3-oxidosqualene cyclase (OSC) inhibitor with IC50 of 6.5 nM; 6 times less potent against hamster and Gottingen minipig liver OSC, and 10-times more potent against squirrel monkey liver OSC; blocks human liver OSC and cholesterol synthesis in HepG2 cells in the nanomolar range; triggers the production of monooxidosqualene, dioxidosqualene, and epoxycholesterol.Dyslipidemia Preclinical
-
同义词Ro-488071
-
通路Others
-
靶点Other Targets
-
受体Other Targets
-
研究领域Cardiovascular Disease
-
适应症Dyslipidemia
化学信息
-
CAS Number161582-11-2
-
分子量448.37
-
分子式C23H27BrFNO2
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESCN(CCCCCCOC1=CC(=C(C=C1)C(=O)C2=CC=C(C=C2)Br)F)CC=C
-
化学全称Methanone, (4-bromophenyl)[2-fluoro-4-[[6-(methyl-2-propen-1-ylamino)hexyl]oxy]phenyl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Morand OH, et al. J Lipid Res. 1997 Feb;38(2):373-90.
2. Peffley DM, et al. Biochem Pharmacol. 1998 Aug 15;56(4):439-49.
3. Liang Y, et al. Onco Targets Ther. 2016 May 30;9:3223-32.
2. Peffley DM, et al. Biochem Pharmacol. 1998 Aug 15;56(4):439-49.
3. Liang Y, et al. Onco Targets Ther. 2016 May 30;9:3223-32.
产品手册
关联产品
-
3beta-Hydroxylanosta...
3beta-Hydroxylanosta-8,24-diene-21-al may have cancer cell growth inhibitory activity against P388, HL-60, L1210 and KB cell lines.
-
2-Tridecanone
2-Tridecanone is a nonalkaloid insecticide isolated from the wild tomato Lycopersicon hirsutum f. glabratum. 2-Tridecanone is a volatile organic compound.
-
Salvianan
Salviane exhibits the most potent cytotoxicity with a CD50 range of 30.4-39.5 microM against HeLa (cervical epitheloid carcinoma), HepG2 (hepatocellular carcinoma), and OVCAR-3 (ovarian adenocarcinoma) cell lines in a dose-dependent manner.